Armodafinil Dosage and Safety Considerations
Special Populations
- For elderly patients, consideration should be given to using lower doses (starting at 100 mg) with close monitoring, as recommended by the American Academy of Sleep Medicine 1
- Armodafinil is contraindicated in pregnancy based on animal data showing potential fetal harm, though human data are insufficient to determine risk, according to the American Academy of Sleep Medicine 2, 3
- The medication may reduce the effectiveness of oral contraceptives, necessitating alternative birth control methods, as suggested by the American Academy of Sleep Medicine 2, 3
Efficacy and Monitoring
- The American Academy of Sleep Medicine suggests armodafinil as a treatment option for narcolepsy in adults (conditional recommendation) 2, 3
Safety and Adverse Effects
- Armodafinil is an FDA Schedule IV controlled substance due to its potential for abuse or dependency, as reported by the American Academy of Sleep Medicine 2, 3
- A 2018 report from the armodafinil/modafinil pregnancy registry showed higher rates of major congenital anomalies in children exposed to the drug in utero, according to the American Academy of Sleep Medicine 2, 3
Important Precautions
- The medication may reduce the effectiveness of hormonal contraceptives, necessitating alternative birth control methods, as suggested by the American Academy of Sleep Medicine 2, 3